TetraScience and Thermo Fisher Scientific Partner to Accelerate Scientific AI Across Biopharma R&D and Manufacturing

   TetraScience, the Scientific Data and AI company,  announced a collaboration with Thermo Fisher Scientific Inc., the world leader in ser...

January 14, 2026 | Wednesday | News
ChemWerth Appoints Chandrakanth Reddy as General Sales Manager in India

-ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengt...

January 13, 2026 | Tuesday | News
QIAGEN CEO Thierry Bernard Outlines 2026 Growth Priorities to Accelerate Path to $2 Billion in Pillar Sales by 2028

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined...

January 13, 2026 | Tuesday | Company results
Aragen Launches CHOMax™ Platform to Accelerate Monoclonal Antibody Development from DNA to IND

Accelerated pathway: Integrated cell line development, process development, analytics, GMP drug substance, plus drug product support through quali...

January 12, 2026 | Monday | News
Codexis and Axolabs Partner to Evaluate Enzymatic RNA Manufacturing Platform

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Gr...

January 12, 2026 | Monday | News
Sharp Sterile Advances Global Growth Strategy With $28M Lee Facility Expansion

Sharp Sterile Manufacturing has  announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will st...

January 09, 2026 | Friday | News
HUTCHMED’s Sovleplenib Meets Primary Endpoint in Phase III ESLIM-02 Trial in wAIHA

— Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease —  HUTCHMED (China) Lim...

January 08, 2026 | Thursday | News
Lonza Licenses Clinically Validated ADC Platform to Sidewinder to Accelerate Bispecific Oncology Pipeline

  Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platform Sidewinder's ...

January 08, 2026 | Thursday | News
Acesion Pharma Enrols First Patients in Phase 2 Trial of Novel Oral AF Therapy

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 i...

January 07, 2026 | Wednesday | News
FUJIFILM Biosciences Name Change Takes Effect As Life Sciences Group Restructuring Moves Into Execution

Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences...

January 06, 2026 | Tuesday | News
WuXi Biologics Achieves ISO 20400 Sustainable Procurement Certification, Strengthening Global Supply Chain Resilience

WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrate...

January 06, 2026 | Tuesday | News
Earendil Labs and Sanofi Forge Strategic Collaboration to Advance AI-Discovered Bispecific Therapies for Autoimmune Diseases

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, announced a strategic collaboration with ...

January 06, 2026 | Tuesday | News
Samsung Bioepis Reclaims European Commercial Rights for BYOOVIZ®, Expanding Direct Biosimilar Portfolio

Samsung Bioepis completes full transfer of commercial rights from Biogen back to Samsung Bioepis for BYOOVIZ® BYOOVIZ becomes the fourth biosimi...

January 05, 2026 | Monday | News
XORTX Highlights Genetic Drivers of Gout and Kidney Disease, Strengthening Case for Xanthine Oxidase Inhibition

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney dis...

January 05, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close